Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2026-06-30 @ 9:54 AM
Study NCT ID:
NCT00471432
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2007-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Sponsor:
NCIC Clinical Trials Group
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent prostate cancer | View |
| None | stage IV prostate cancer | View |
| None | recurrent renal cell cancer | View |
| None | stage IV renal cell cancer | View |
| None | recurrent non-small cell lung cancer | View |
| None | stage IV non-small cell lung cancer | View |
| None | recurrent bladder cancer | View |
| None | stage IV bladder cancer | View |
| None | recurrent breast cancer | View |
| None | stage IV breast cancer | View |
| None | recurrent ovarian epithelial cancer | View |
| None | stage IV ovarian epithelial cancer | View |
| None | unspecified adult solid tumor, protocol specific | View |
| None | male breast cancer | View |